- Home
- LYRA vs MHUA Comparison
LYRA vs MHUA Comparison
Compare LYRA & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- MHUA
- Stock Information
- Founded
- LYRA 2005
- MHUA 1990
- Country
- LYRA United States
- MHUA China
- Employees
- LYRA N/A
- MHUA N/A
- Industry
- LYRA Medical/Dental Instruments
- MHUA Medical Specialities
- Sector
- LYRA Health Care
- MHUA Health Care
- Exchange
- LYRA Nasdaq
- MHUA Nasdaq
- Market Cap
- LYRA 13.5M
- MHUA 15.6M
- IPO Year
- LYRA 2020
- MHUA 2022
- Fundamental
- Price
- LYRA $0.19
- MHUA $0.32
- Analyst Decision
- LYRA Buy
- MHUA
- Analyst Count
- LYRA 5
- MHUA 0
- Target Price
- LYRA $4.50
- MHUA N/A
- AVG Volume (30 Days)
- LYRA 1.9M
- MHUA 897.2K
- Earning Date
- LYRA 11-12-2024
- MHUA 09-20-2024
- Dividend Yield
- LYRA N/A
- MHUA N/A
- EPS Growth
- LYRA N/A
- MHUA 29.93
- EPS
- LYRA N/A
- MHUA 0.37
- Revenue
- LYRA $1,471,000.00
- MHUA $94,252,537.00
- Revenue This Year
- LYRA N/A
- MHUA N/A
- Revenue Next Year
- LYRA N/A
- MHUA N/A
- P/E Ratio
- LYRA N/A
- MHUA $0.89
- Revenue Growth
- LYRA 3.37
- MHUA N/A
- 52 Week Low
- LYRA $0.16
- MHUA $0.25
- 52 Week High
- LYRA $6.79
- MHUA $1.47
- Technical
- Relative Strength Index (RSI)
- LYRA 46.20
- MHUA 37.70
- Support Level
- LYRA $0.18
- MHUA $0.30
- Resistance Level
- LYRA $0.22
- MHUA $0.35
- Average True Range (ATR)
- LYRA 0.02
- MHUA 0.03
- MACD
- LYRA -0.00
- MHUA 0.01
- Stochastic Oscillator
- LYRA 16.31
- MHUA 36.35
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.